Kliničke studije za Astma u državi Texas
20 studija za Astma traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
- Dallas10 studija
- Houston8 studija
- San Antonio6 studija
- Austin5 studija
- McKinney5 studija
- El Paso4 studija
- Cypress3 studija
- The Woodlands3 studija
- Sugar Land3 studija
Službeni tekst studije (engleski)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Cypress
- GSK Investigational Site, Tomball
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Dallas
- GSK Investigational Site, Kerrville
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Austin
- Research Site, Boerne
- Research Site, Dallas
- i još 6
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, McKinney
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07301255A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 17, San Antonio
- Research Site 07, Sugar Land
U tijeku regrutacijaFaza 3
Od 12 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Horizon Clinical Research Group, Cypress
- Alina Clinical Trials, LLC., Dallas
- i još 2
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Dallas
- Research Site, Houston
- Research Site, San Antonio
U tijeku regrutacijaFaza 3
Od 5 do 11 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06023589A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 24, Amarillo
- Research Site 19, Baytown
- Research Site 07, Dallas
- i još 6
U tijeku regrutacijaFaza 3
Od 12 do 80 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07276724A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12083, Austin
- Teva Investigational Site 12060, Austin
- Teva Investigational Site 12179, Cypress
- i još 13
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Lewisville
- Research Site, San Antonio
U tijeku regrutacijaFaza 2
Od 4 do 11 godina · Oba spola · Ažurirano 27. kol 2026. · NCT07525375A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, San Antonio
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Austin
- Research Site, Baytown
- Research Site, Beaumont
- i još 12
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 13. kol 2026. · NCT06307665A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
- GSK Investigational Site, Austin
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 60 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07712393A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Dallas
- Research site, Houston
- Research site, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 28. srp 2026. · NCT07532265Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
- Orion Clinical Research, Austin
- Pharmaceutical Research & Consulting, Inc., Dallas
- Western Sky Medical Research, El Paso
U tijeku regrutacijaOpažajna studija
Od 5 do 100 godina · Oba spola · Ažurirano 2. lip 2026. · NCT07228026Escitalopram in Asthma Patients With Frequent Exacerbation
- UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 26. sij 2026. · NCT06216535Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 16. sij 2026. · NCT06273072Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
- University of Texas at Arlington, Arlington
- Rebuilding Together North Texas, Plano
U tijeku regrutacija
Od 5 godina i više · Oba spola · Ažurirano 29. lis 2025. · NCT07196436Individualizing Treatment for Asthma in Primary Care (Full Study)
- JPS Health Network, Fort Worth
- Kelsey Research Foundation, Houston
U tijeku regrutacijaFaza 4
Od 13 do 75 godina · Oba spola · Ažurirano 29. lis 2025. · NCT07052942Viral Mucosal Reprogramming
- University of Texas Medical Branch, Galveston
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 do 60 godina · Oba spola · Ažurirano 28. sij 2025. · NCT05331170Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.